Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV ® Active Ingredients.
Camille JacquesFlora MarchandMathias ChatelaisAdrien BrulefertIlaria FlorisPublished in: Life (Basel, Switzerland) (2024)
in its employment as a therapeutic intervention for EBV-associated diseases.